Bio-Techne (TECH) Cash from Operations Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.97% |
| Dec 31, 2025 | -1.59% |
| Sep 30, 2025 | -16.01% |
| Jun 30, 2025 | 17.00% |
| Mar 31, 2025 | -3.63% |
| Dec 31, 2024 | 3.68% |
| Sep 30, 2024 | 9.52% |
| Jun 30, 2024 | 6.18% |
| Mar 31, 2024 | 15.35% |
| Dec 31, 2023 | 12.29% |
| Sep 30, 2023 | 8.52% |
| Jun 30, 2023 | 5.16% |
| Mar 31, 2023 | 18.48% |
| Dec 31, 2022 | 10.44% |
| Sep 30, 2022 | 4.64% |
| Jun 30, 2022 | 15.10% |
| Mar 31, 2022 | 23.93% |
| Dec 31, 2021 | 19.39% |
| Sep 30, 2021 | 12.82% |
| Jun 30, 2021 | 27.20% |
| Mar 31, 2021 | 15.05% |
| Dec 31, 2020 | 18.29% |
| Sep 30, 2020 | 15.70% |
| Jun 30, 2020 | 3.82% |
| Mar 31, 2020 | 9.96% |
| Dec 31, 2019 | 14.54% |
| Sep 30, 2019 | 2.56% |
| Jun 30, 2019 | 8.09% |
| Mar 31, 2019 | 2.57% |
| Dec 31, 2018 | 8.25% |
| Sep 30, 2018 | 3.90% |
| Jun 30, 2018 | 16.68% |
| Mar 31, 2018 | -8.10% |
| Dec 31, 2017 | 4.60% |
| Sep 30, 2017 | 8.84% |
| Jun 30, 2017 | 6.33% |
| Mar 31, 2017 | -6.20% |
| Dec 31, 2016 | 15.29% |
| Sep 30, 2016 | -5.10% |
| Jun 30, 2016 | 1.11% |
| Mar 31, 2016 | 2.78% |
| Dec 31, 2015 | 5.54% |
| Sep 30, 2015 | 0.73% |
| Jun 30, 2015 | 3.17% |
| Mar 31, 2015 | 5.80% |
| Dec 31, 2014 | 4.82% |
| Sep 30, 2014 | 4.97% |